Dr. Anosheh Afghahi
Claim this profileGSK Investigational Site
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied
Area of expertise
1Breast Cancer
Stage III
BRCA positive
HER2 negative
2Cancer
HER2 negative
BRCA1 positive
Stage III
Affiliated Hospitals
More about Anosheh Afghahi
Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Anosheh Afghahi has experience with
- Atezolizumab
- Olaparib
- Niraparib
- Placebo
Breakdown of trials Anosheh Afghahi has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anosheh Afghahi specialize in?
Anosheh Afghahi focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are BRCA positive.
Is Anosheh Afghahi currently recruiting for clinical trials?
No, Anosheh Afghahi is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Anosheh Afghahi has studied deeply?
Yes, Anosheh Afghahi has studied treatments such as Atezolizumab, Olaparib, Niraparib.
What is the best way to schedule an appointment with Anosheh Afghahi?
Apply for one of the trials that Anosheh Afghahi is conducting.
What is the office address of Anosheh Afghahi?
The office of Anosheh Afghahi is located at: GSK Investigational Site, Aurora, Colorado 80045 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.